# Phase 1/2 hypertension trials recruiting: 20 (November 2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 20 trials in phase 1/2 for hypertension that are recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Recruiting Phase 1/2 hypertension trials: 20 rows for $5, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email.

Buy: https://specstream.ai/data/clinical-trials/recruiting/phase-1-2/hypertension

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 20
- Recruiting or not yet: 20
- Read on: November 19, 2026

## Trials

The 20 newest of 20, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| August 11, 2026 | NCT07758634 | A Trial Evaluating Safety, Tolerability and Efficacy of CTX340 in Participants With Hypertension | CRISPR Therapeutics AG | Phase 1/2 | Recruiting | Hypertension | 69 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07758634) |
| July 31, 2026 | NCT07738562 | Dipyridamole for Early-Onset Preeclampsia: A Pilot Study of Feasibility, Pharmacokinetics, and Biological Effects | Hadassah Medical Organization | Phase 1/2 | Not yet recruiting | Preeclampsia (PE), Hypertension ,Pregnancy | 15 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07738562) |
| June 30, 2026 | NCT07675824 | REGN22530 for Adults With Primary Open Angle Glaucoma or Ocular Hypertension | Regeneron Pharmaceuticals | Phase 1/2 | Recruiting | Primary Open Angle Glaucoma (POAG), Ocular Hypertension (OHT) | 271 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07675824) |
| June 8, 2026 | NCT07632235 | A Multicenter, Prospective, Randomized, Open-label Phase Ib/II Study of Celecoxib Plus Pembrolizumab and Gemcitabine/Cisplatin Versus... | Shanghai 6th People's Hospital | Phase 1/2 | Not yet recruiting | Intrahepatic Cholangiocarcinoma (Icc) | 112 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07632235) |
| June 3, 2026 | NCT07623525 | DIAG723 in Adults With Hereditary Hemorrhagic Telangiectasia | Diagonal Therapeutics, Inc. | Phase 1/2 | Recruiting | Hereditary Hemorrhagic Telangiectasia, Pulmonary Arterial Hypertension | 93 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07623525) |
| January 22, 2026 | NCT07357974 | Impact of Sotatercept on Pulmonary Artery and Right Ventricle Remodeling Imaging Assessed With 68Ga-FAPI PET/CT in Patients With PAH | University Hospital, Brest | Phase 1/2 | Not yet recruiting | Pulmonary Arterial Hypertension (PAH) | 15 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07357974) |
| November 3, 2025 | NCT07223528 | TEPH: Telaglenastat Efficacy in Pulmonary Hypertension | Sponsor not shown (see the record) | Phase 1/2 | Not yet recruiting | Pulmonary Hypertension | 28 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07223528) |
| August 27, 2025 | NCT07143448 | A Study of HS235 for Treatment of Pulmonary Arterial Hypertension (PAH) in Adults | 35Pharma Inc., a GSK company | Phase 1/2 | Recruiting | Pulmonary Arterial Hypertension | 90 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07143448) |
| August 14, 2025 | NCT07123779 | HS235 Study in Overweight and Obese Participants With Combined Pre and Post-Capillary Pulmonary Hypertension Due to Heart Failure With... | 35Pharma Inc., a GSK company | Phase 1/2 | Recruiting | Pulmonary Hypertension, Heart Failure With Preserved Ejection Fraction | 126 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07123779) |
| June 25, 2025 | NCT07036510 | Safety and Efficacy of TimoD Sustained-Release Implant in Participants With Glaucoma or Ocular Hypertension Undergoing Cataract Surgery | EyeD Pharma | Phase 1/2 | Recruiting | Glaucoma, Ocular Hypertension | 42 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07036510) |
| January 31, 2025 | NCT06802380 | Neuromodulation in Patients With Pulmonary Arterial Hypertension | University of Oklahoma | Phase 1/2 | Not yet recruiting | Pulmonary Hypertension | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06802380) |
| December 2, 2024 | NCT06712186 | Effect of Dexmedetomidine on Hemodynamic Response to Endotracheal Intubation in Hypertensive Patients | Liaquat National Hospital & Medical College | Phase 1/2 | Recruiting | Elective Surgical Patient, Hypertensive Patients, Blood Pressure, Hypertensive Elderly Patients, Anxiolytic | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06712186) |
| October 18, 2024 | NCT06649110 | A Study to Learn About the Treatment LTP001 in Healthy Participants (Part A) and in Participants With PAH (Part B) | Novartis Pharmaceuticals | Phase 1/2 | Recruiting | Healthy Volunteers, Pulmonary Arterial Hypertension | 232 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06649110) |
| November 22, 2023 | NCT06143566 | Polypill for Prevention of Cardiomyopathy | University of Texas Southwestern Medical Center | Phase 1/2 | Recruiting | Type 2 Diabetes, High Blood Pressure | 200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06143566) |
| September 6, 2023 | NCT06025630 | Targeting Endoplasmic Reticulum Stress in Human Hypertension | University of North Texas Health Science Center | Phase 1/2 | Recruiting | Hypertension | 70 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06025630) |
| February 27, 2023 | NCT05746039 | Feasibility of Semaglutide in Advanced Lung Disease | University of Pennsylvania | Phase 1/2 | Recruiting | Obesity, Interstitial Lung Disease, Chronic Obstructive Pulmonary Disease, Sarcoidosis, Pulmonary, Pulmonary... | 8 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05746039) |
| April 6, 2022 | NCT05312892 | Sympathetic Mechanisms in Obesity-Crossover Design | Vanderbilt University Medical Center | Phase 1/2 | Recruiting | Obesity, Hypertension | 12 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05312892) |
| January 20, 2021 | NCT04715022 | Sympathetic-vascular Dysfunction in Obesity and Insulin Resistance (Vitamin C Study) | University of Kansas Medical Center | Phase 1/2 | Recruiting | Hypertension, Cardiovascular Diseases | 23 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04715022) |
| November 18, 2020 | NCT04633356 | EUS Guided Portal-systemic Pressure Gradient Measurement | Chinese University of Hong Kong | Phase 1/2 | Recruiting | Portal Hypertension, Cirrhosis | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04633356) |
| November 20, 2015 | NCT02608996 | Nesiritide in Hypertension | Oslo University Hospital | Phase 1/2 | Recruiting | Hypertension | 15 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02608996) |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| 35Pharma Inc., a GSK company | 2 |
| Liaquat National Hospital & Medical College | 1 |
| Shanghai 6th People's Hospital | 1 |
| University of North Texas Health Science Center | 1 |
| Chinese University of Hong Kong | 1 |
| Hadassah Medical Organization | 1 |
| University of Kansas Medical Center | 1 |
| Diagonal Therapeutics, Inc. | 1 |
| Vanderbilt University Medical Center | 1 |
| CRISPR Therapeutics AG | 1 |
| University of Pennsylvania | 1 |
| EyeD Pharma | 1 |
| [Novartis Pharmaceuticals](https://specstream.ai/data/clinical-trials/company/novartis-pharmaceuticals) | 1 |
| [Regeneron Pharmaceuticals](https://specstream.ai/data/clinical-trials/company/regeneron-pharmaceuticals) | 1 |
| University Hospital, Brest | 1 |
| University of Oklahoma | 1 |
| Oslo University Hospital | 1 |
| University of Texas Southwestern Medical Center | 1 |

## By country

| Country | Trials |
| --- | --- |
| United States | 12 |
| Australia | 3 |
| United Kingdom | 3 |
| China | 2 |
| Spain | 2 |
| France | 2 |
| Pakistan | 1 |
| Israel | 1 |
| Canada | 1 |
| New Zealand | 1 |
| Panama | 1 |
| Argentina | 1 |
| Belgium | 1 |
| Brazil | 1 |
| Czechia | 1 |
| Germany | 1 |
| Greece | 1 |
| Italy | 1 |
| Latvia | 1 |
| Mexico | 1 |
| Poland | 1 |
| Portugal | 1 |
| Romania | 1 |
| Serbia | 1 |
| Norway | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Road contractors in the United States](https://specstream.ai/data/businesses/road-contractors/united-states)
- [Crane services in the United States](https://specstream.ai/data/businesses/crane-services/united-states)
- [Plasterers in the United States](https://specstream.ai/data/businesses/plasterers/united-states)
- [Cafes in the United States](https://specstream.ai/data/businesses/cafes/united-states)
- [Music schools in the United States](https://specstream.ai/data/businesses/music-schools/united-states)
- [B2B oil and gas extraction companies in the United States](https://specstream.ai/data/businesses/b2b-oil-and-gas-extraction-companies/united-states)
